Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03650322
Other study ID # 18922
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2018
Est. completion date May 30, 2020

Study information

Verified date June 2023
Source University of Illinois at Urbana-Champaign
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators propose to compare the effects of a 12-week, supervised, site-based group yoga intervention on cognitive function, functional fitness, and well-being in middle-aged cancer survivors. Subjects will be randomly assigned to one of three exercise conditions: a yoga group, an aerobic walking group or a strength training group. All sessions (2-3 times per week) will be led by a trained exercise leader for a total of 150 minutes of exercise each week for the 12-week intervention.


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date May 30, 2020
Est. primary completion date May 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria: - 30-70 years of age - Cancer diagnosis - 1 year since last cancer treatment (surgery, chemotherapy, and/or radiation) - Not planning to receive treatment during study period - Completion of Physical Activity Readiness Questionnaire (PAR-Q) - Ambulatory and absence of health conditions that may be exacerbated by yoga, walking, or strength training - Physician consent (if deemed necessary) - Low-active, i.e. less than 150 minutes/week of moderate to vigorous exercise, no current yoga practice (including within last six months) - Intention to remain in the Champaign-Urbana area over the study duration - Willingness to be randomly assigned to one of the three groups (yoga, aerobic walking, strength training) - Comfortable with reading, writing, and speaking English Exclusion Criteria: - Below 30 or above 70 years of age - Cancer diagnosis of the brain - Less than 1 year since last treatment (surgery, chemotherapy, and/or radiation) or plans to receive treatment during study - Determined ambulatory or 'high risk' based on responses to PAR-Q - High-active (exercising more than 150 minutes/week in the last six months) - No consent from physician - Intent to be away from the Champaign-Urbana area for an extended period of time during the study - Inability to communicate effectively in English

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Yoga
12 weeks, total of 150 minutes of exercise per week.
Stretching and Toning
12 weeks, total of 150 minutes of exercise per week.
Aerobic Walking
12 weeks, total of 150 minutes of exercise per week.

Locations

Country Name City State
United States University of Illinois at Urbana-Champaign Urbana Illinois

Sponsors (1)

Lead Sponsor Collaborator
University of Illinois at Urbana-Champaign

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Feasibility: Recruitment and retention rates Proportion of participants randomized relative to total contacts, Proportion of participants who complete follow-up questionnaires, Baseline to 12-weeks
Primary Cognitive Function Participants will complete part of the NIH Toolbox measures that assess cognitive function. Change from baseline to 12 weeks will be reported
Secondary Cardiovascular Function Participants will complete a submaximal exercise test to reach a target heart rate within 85% of the age-predicted maximum. Change from baseline to 12 weeks will be reported
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients

External Links